ROSEVILLE, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of Viral Genetics (OTCBB:VRAL) maintaining a Neutral rating. The 12-page report by Dutton senior analyst Wayne Lottinville, CFA is available at http://www.jmdutton.com/research/VRAL/index.html as well as from First Call, Bloomberg Professional, Zacks, Reuters, Knobias, and other leading financial portals.
